Bay City Capital
Overview
Bay City Capital is a life sciences investment firm with a global diversified strategy ranging from seed stage to public companies, and including innovation, restructuring opportunities, and growth investing . The firm seeks to invest in the life sciences industry, with a focus on investing in companies within the bio-pharmaceuticals, drug discovery, medical devices, nutrition, healthcare IT, and medical diagnostics sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NexCure, Inc. | Nov 2018 | Series B | Co-investor |
| KBP Biosciences | Jan 2018 | Series A | Co-investor |
| Vivaldi Biosciences, Inc. | Jan 2009 | Series A | Lead |
| Synchronicity Pharma | Feb 2016 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bay City Capital based?
Bay City Capital is headquartered in San Rafael, California, United States.
When was Bay City Capital founded?
Bay City Capital was founded in 1997.
How many portfolio companies does Bay City Capital have?
Bay City Capital has 6 portfolio companies in Caplight's dataset.
What are some companies in Bay City Capital's portfolio?
Portfolio companies visible on Caplight include NexCure, Inc., KBP Biosciences, Vivaldi Biosciences, Inc., Synchronicity Pharma.
What was Bay City Capital's most recent investment shown here?
Bay City Capital's most recent investment in this portfolio sample was in NexCure, Inc. in 2018.
What sectors does Bay City Capital focus on?
Bay City Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Bay City Capital focus on?
Bay City Capital typically invests at the MultiStage stage.
What is Bay City Capital's AUM?
Bay City Capital's assets under management are estimated between $1.0B and $10.0B.